CovidFranceV1, Main, Exploration, bibRecord, 000D64

Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network.

Identifieur interne : 000D64 ( Main/Exploration ); précédent : 000D63; suivant : 000D65

Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network.

Auteurs : Bernadette Van Den Hoogen [Pays-Bas] ; Angela Santoni [Italie] ; Giuseppe Sciumé [Italie] ; Andrew Bowie [Irlande (pays)] ; Cliona O'Farrelly [Irlande (pays)] ; Luke O'Neill [Irlande (pays)] ; Marit Anthonsen [Norvège] ; Katerina Pardali [Suède] ; Simon Young [Suède] ; Andreas Bergthaler [Autriche] ; Nicolas Manel [France] ; Roland Zahn [Pays-Bas] ; Marjolein Kikkert [Pays-Bas] ; Eric Snijder [Pays-Bas] ; Frank Van Kuppeveld [Pays-Bas] ; Ron Fouchier [Pays-Bas] ; John Hiscott [Italie]

Source :

Virus research [ 1872-7492 ] ; 2020.

RBID : pubmed:32730781

Descripteurs français

KwdFr :
- Antiviraux (usage thérapeutique), Betacoronavirus (effets des médicaments et des substances chimiques), Betacoronavirus (immunologie), Enseignement médical (méthodes), Humains (MeSH), Immunité innée (immunologie), Infections à coronavirus (traitement médicamenteux), Infections à coronavirus (économie), Interactions hôte-pathogène (physiologie), Pandémies (économie), Pneumopathie virale (traitement médicamenteux), Pneumopathie virale (économie), Prestations des soins de santé (méthodes), Prestations des soins de santé (économie), Recherche biomédicale (méthodes).
MESH :
- effets des médicaments et des substances chimiques : Betacoronavirus.
- immunologie : Betacoronavirus, Immunité innée.
- méthodes : Enseignement médical, Prestations des soins de santé, Recherche biomédicale.
- physiologie : Interactions hôte-pathogène.
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale.
- usage thérapeutique : Antiviraux.
- économie : Infections à coronavirus, Pandémies, Pneumopathie virale, Prestations des soins de santé.
- Humains.

English descriptors

KwdEn :
- Antiviral Agents (therapeutic use), Betacoronavirus (drug effects), Betacoronavirus (immunology), Biomedical Research (methods), Coronavirus Infections (drug therapy), Coronavirus Infections (economics), Delivery of Health Care (economics), Delivery of Health Care (methods), Education, Medical (methods), Host-Pathogen Interactions (physiology), Humans (MeSH), Immunity, Innate (immunology), Pandemics (economics), Pneumonia, Viral (drug therapy), Pneumonia, Viral (economics).
MESH :
- chemical , therapeutic use : Antiviral Agents.
- drug effects : Betacoronavirus.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- economics : Coronavirus Infections, Delivery of Health Care, Pandemics, Pneumonia, Viral.
- immunology : Betacoronavirus, Immunity, Innate.
- methods : Biomedical Research, Delivery of Health Care, Education, Medical.
- physiology : Host-Pathogen Interactions.
- Humans.

Abstract

The past century has witnessed major advances in the control of many infectious diseases, yet outbreaks and epidemics caused by (re-) emerging RNA viruses continue to pose a global threat to human health. As illustrated by the global COVID19 pandemic, high healthcare costs, economic disruption and loss of productivity reinforce the unmet medical need to develop new antiviral strategies to combat not only the current pandemic but also future viral outbreaks. Pivotal for effective anti-viral defense is the innate immune system, a first line host response that senses and responds to virus infection. While molecular details of the innate immune response are well characterized, this research field is now being revolutionized with the recognition that cell metabolism has a major impact on the antiviral and inflammatory responses to virus infections. A detailed understanding of the role of metabolic regulation with respect to antiviral and inflammatory responses, together with knowledge of the strategies used by viruses to exploit immunometabolic pathways, will ultimately change our understanding and treatment of pathogenic viral diseases. INITIATE is a Marie Sklodowska-Curie Actions Innovative Training Network (MSCA-ITN), with the goal to train 15 early stage PhD researchers (ESRs) to become experts in antiviral immunometabolism (https://initiate-itn.eu/). To this end, INITIATE brings together a highly complementary international team of academic and corporate leaders from 7 European countries, with outstanding track records in the historically distinct research fields of virology, immunology and metabolism. The ESRs of INITIATE are trained in these interdisciplinary research fields through individual investigator-driven research projects, specialized scientific training events, workshops on academia-industry interactions, outreach & communication. INITIATE will deliver a new generation of creative and entrepreneurial researchers who will be able to face the inevitable future challenges in combating viral diseases.

DOI: 10.1016/j.virusres.2020.198094
PubMed: 32730781
PubMed Central: PMC7384980

Affiliations:

Autriche, France, Irlande (pays), Italie, Norvège, Pays-Bas, Suède
Hollande-Méridionale, Latium, Trøndelag, Utrecht (province), Vienne (Autriche), Île-de-France
Leyde, Paris, Rome, Rotterdam, Trondheim, Utrecht, Vienne (Autriche)
Université d'Utrecht

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000785
to stream Main, to step Curation: 000785

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network.</title>
<author><name sortKey="Van Den Hoogen, Bernadette" sort="Van Den Hoogen, Bernadette" uniqKey="Van Den Hoogen B" first="Bernadette" last="Van Den Hoogen">Bernadette Van Den Hoogen</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Viroscience, Erasmus MC, 3015 GD, Rotterdam, the Netherlands. Electronic address: b.vandenhoogen@erasmusmc.nl.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Department of Viroscience, Erasmus MC, 3015 GD, Rotterdam</wicri:regionArea>
<placeName><settlement type="city">Rotterdam</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Santoni, Angela" sort="Santoni, Angela" uniqKey="Santoni A" first="Angela" last="Santoni">Angela Santoni</name>
<affiliation wicri:level="3"><nlm:affiliation>Istituto Pasteur Italia Cenci Bolognetti Foundation, 00161, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Istituto Pasteur Italia Cenci Bolognetti Foundation, 00161, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sciume, Giuseppe" sort="Sciume, Giuseppe" uniqKey="Sciume G" first="Giuseppe" last="Sciumé">Giuseppe Sciumé</name>
<affiliation wicri:level="3"><nlm:affiliation>Istituto Pasteur Italia Cenci Bolognetti Foundation, 00161, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Istituto Pasteur Italia Cenci Bolognetti Foundation, 00161, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bowie, Andrew" sort="Bowie, Andrew" uniqKey="Bowie A" first="Andrew" last="Bowie">Andrew Bowie</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152 - 160 Pearse St., Dublin 2, Ireland.</nlm:affiliation>
<country xml:lang="fr">Irlande (pays)</country>
<wicri:regionArea>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152 - 160 Pearse St., Dublin 2</wicri:regionArea>
<wicri:noRegion>Dublin 2</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="O Farrelly, Cliona" sort="O Farrelly, Cliona" uniqKey="O Farrelly C" first="Cliona" last="O'Farrelly">Cliona O'Farrelly</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152 - 160 Pearse St., Dublin 2, Ireland.</nlm:affiliation>
<country xml:lang="fr">Irlande (pays)</country>
<wicri:regionArea>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152 - 160 Pearse St., Dublin 2</wicri:regionArea>
<wicri:noRegion>Dublin 2</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="O Neill, Luke" sort="O Neill, Luke" uniqKey="O Neill L" first="Luke" last="O'Neill">Luke O'Neill</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152 - 160 Pearse St., Dublin 2, Ireland.</nlm:affiliation>
<country xml:lang="fr">Irlande (pays)</country>
<wicri:regionArea>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152 - 160 Pearse St., Dublin 2</wicri:regionArea>
<wicri:noRegion>Dublin 2</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Anthonsen, Marit" sort="Anthonsen, Marit" uniqKey="Anthonsen M" first="Marit" last="Anthonsen">Marit Anthonsen</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Laboratory Medicine, Children's and Women's Health, Faculty of Medicine, Norwegian University of Science and Technology, 7006, Trondheim, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Department of Laboratory Medicine, Children's and Women's Health, Faculty of Medicine, Norwegian University of Science and Technology, 7006, Trondheim</wicri:regionArea>
<placeName><settlement type="city">Trondheim</settlement>
<region type="région" nuts="2">Trøndelag</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pardali, Katerina" sort="Pardali, Katerina" uniqKey="Pardali K" first="Katerina" last="Pardali">Katerina Pardali</name>
<affiliation wicri:level="1"><nlm:affiliation>AstraZeneca, Pepparedsleden 1, 431 50, Mölndal, Gothenburg, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>AstraZeneca, Pepparedsleden 1, 431 50, Mölndal, Gothenburg</wicri:regionArea>
<wicri:noRegion>Gothenburg</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Young, Simon" sort="Young, Simon" uniqKey="Young S" first="Simon" last="Young">Simon Young</name>
<affiliation wicri:level="1"><nlm:affiliation>AstraZeneca, Pepparedsleden 1, 431 50, Mölndal, Gothenburg, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>AstraZeneca, Pepparedsleden 1, 431 50, Mölndal, Gothenburg</wicri:regionArea>
<wicri:noRegion>Gothenburg</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bergthaler, Andreas" sort="Bergthaler, Andreas" uniqKey="Bergthaler A" first="Andreas" last="Bergthaler">Andreas Bergthaler</name>
<affiliation wicri:level="3"><nlm:affiliation>CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090, Vienna, Austria.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090, Vienna</wicri:regionArea>
<placeName><settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Manel, Nicolas" sort="Manel, Nicolas" uniqKey="Manel N" first="Nicolas" last="Manel">Nicolas Manel</name>
<affiliation wicri:level="3"><nlm:affiliation>Stimunity, 57 Rue d'Amsterdam, 75008, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Stimunity, 57 Rue d'Amsterdam, 75008, Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zahn, Roland" sort="Zahn, Roland" uniqKey="Zahn R" first="Roland" last="Zahn">Roland Zahn</name>
<affiliation wicri:level="3"><nlm:affiliation>Janssen Vaccines & Prevention B.V., 2333 CN, Leiden, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Janssen Vaccines & Prevention B.V., 2333 CN, Leiden</wicri:regionArea>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kikkert, Marjolein" sort="Kikkert, Marjolein" uniqKey="Kikkert M" first="Marjolein" last="Kikkert">Marjolein Kikkert</name>
<affiliation wicri:level="3"><nlm:affiliation>Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, 2333 ZA, Leiden, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, 2333 ZA, Leiden</wicri:regionArea>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Snijder, Eric" sort="Snijder, Eric" uniqKey="Snijder E" first="Eric" last="Snijder">Eric Snijder</name>
<affiliation wicri:level="3"><nlm:affiliation>Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, 2333 ZA, Leiden, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, 2333 ZA, Leiden</wicri:regionArea>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Van Kuppeveld, Frank" sort="Van Kuppeveld, Frank" uniqKey="Van Kuppeveld F" first="Frank" last="Van Kuppeveld">Frank Van Kuppeveld</name>
<affiliation wicri:level="4"><nlm:affiliation>Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL, Utrecht, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL, Utrecht</wicri:regionArea>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
<orgName type="university">Université d'Utrecht</orgName>
</affiliation>
</author>
<author><name sortKey="Fouchier, Ron" sort="Fouchier, Ron" uniqKey="Fouchier R" first="Ron" last="Fouchier">Ron Fouchier</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Viroscience, Erasmus MC, 3015 GD, Rotterdam, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Department of Viroscience, Erasmus MC, 3015 GD, Rotterdam</wicri:regionArea>
<placeName><settlement type="city">Rotterdam</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hiscott, John" sort="Hiscott, John" uniqKey="Hiscott J" first="John" last="Hiscott">John Hiscott</name>
<affiliation wicri:level="3"><nlm:affiliation>Istituto Pasteur Italia Cenci Bolognetti Foundation, 00161, Rome, Italy. Electronic address: john.hiscott@istitutopasteur.it.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Istituto Pasteur Italia Cenci Bolognetti Foundation, 00161, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32730781</idno>
<idno type="pmid">32730781</idno>
<idno type="doi">10.1016/j.virusres.2020.198094</idno>
<idno type="pmc">PMC7384980</idno>
<idno type="wicri:Area/Main/Corpus">000785</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000785</idno>
<idno type="wicri:Area/Main/Curation">000785</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000785</idno>
<idno type="wicri:Area/Main/Exploration">000785</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network.</title>
<author><name sortKey="Van Den Hoogen, Bernadette" sort="Van Den Hoogen, Bernadette" uniqKey="Van Den Hoogen B" first="Bernadette" last="Van Den Hoogen">Bernadette Van Den Hoogen</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Viroscience, Erasmus MC, 3015 GD, Rotterdam, the Netherlands. Electronic address: b.vandenhoogen@erasmusmc.nl.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Department of Viroscience, Erasmus MC, 3015 GD, Rotterdam</wicri:regionArea>
<placeName><settlement type="city">Rotterdam</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Santoni, Angela" sort="Santoni, Angela" uniqKey="Santoni A" first="Angela" last="Santoni">Angela Santoni</name>
<affiliation wicri:level="3"><nlm:affiliation>Istituto Pasteur Italia Cenci Bolognetti Foundation, 00161, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Istituto Pasteur Italia Cenci Bolognetti Foundation, 00161, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sciume, Giuseppe" sort="Sciume, Giuseppe" uniqKey="Sciume G" first="Giuseppe" last="Sciumé">Giuseppe Sciumé</name>
<affiliation wicri:level="3"><nlm:affiliation>Istituto Pasteur Italia Cenci Bolognetti Foundation, 00161, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Istituto Pasteur Italia Cenci Bolognetti Foundation, 00161, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bowie, Andrew" sort="Bowie, Andrew" uniqKey="Bowie A" first="Andrew" last="Bowie">Andrew Bowie</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152 - 160 Pearse St., Dublin 2, Ireland.</nlm:affiliation>
<country xml:lang="fr">Irlande (pays)</country>
<wicri:regionArea>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152 - 160 Pearse St., Dublin 2</wicri:regionArea>
<wicri:noRegion>Dublin 2</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="O Farrelly, Cliona" sort="O Farrelly, Cliona" uniqKey="O Farrelly C" first="Cliona" last="O'Farrelly">Cliona O'Farrelly</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152 - 160 Pearse St., Dublin 2, Ireland.</nlm:affiliation>
<country xml:lang="fr">Irlande (pays)</country>
<wicri:regionArea>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152 - 160 Pearse St., Dublin 2</wicri:regionArea>
<wicri:noRegion>Dublin 2</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="O Neill, Luke" sort="O Neill, Luke" uniqKey="O Neill L" first="Luke" last="O'Neill">Luke O'Neill</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152 - 160 Pearse St., Dublin 2, Ireland.</nlm:affiliation>
<country xml:lang="fr">Irlande (pays)</country>
<wicri:regionArea>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152 - 160 Pearse St., Dublin 2</wicri:regionArea>
<wicri:noRegion>Dublin 2</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Anthonsen, Marit" sort="Anthonsen, Marit" uniqKey="Anthonsen M" first="Marit" last="Anthonsen">Marit Anthonsen</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Laboratory Medicine, Children's and Women's Health, Faculty of Medicine, Norwegian University of Science and Technology, 7006, Trondheim, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Department of Laboratory Medicine, Children's and Women's Health, Faculty of Medicine, Norwegian University of Science and Technology, 7006, Trondheim</wicri:regionArea>
<placeName><settlement type="city">Trondheim</settlement>
<region type="région" nuts="2">Trøndelag</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pardali, Katerina" sort="Pardali, Katerina" uniqKey="Pardali K" first="Katerina" last="Pardali">Katerina Pardali</name>
<affiliation wicri:level="1"><nlm:affiliation>AstraZeneca, Pepparedsleden 1, 431 50, Mölndal, Gothenburg, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>AstraZeneca, Pepparedsleden 1, 431 50, Mölndal, Gothenburg</wicri:regionArea>
<wicri:noRegion>Gothenburg</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Young, Simon" sort="Young, Simon" uniqKey="Young S" first="Simon" last="Young">Simon Young</name>
<affiliation wicri:level="1"><nlm:affiliation>AstraZeneca, Pepparedsleden 1, 431 50, Mölndal, Gothenburg, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>AstraZeneca, Pepparedsleden 1, 431 50, Mölndal, Gothenburg</wicri:regionArea>
<wicri:noRegion>Gothenburg</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bergthaler, Andreas" sort="Bergthaler, Andreas" uniqKey="Bergthaler A" first="Andreas" last="Bergthaler">Andreas Bergthaler</name>
<affiliation wicri:level="3"><nlm:affiliation>CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090, Vienna, Austria.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090, Vienna</wicri:regionArea>
<placeName><settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Manel, Nicolas" sort="Manel, Nicolas" uniqKey="Manel N" first="Nicolas" last="Manel">Nicolas Manel</name>
<affiliation wicri:level="3"><nlm:affiliation>Stimunity, 57 Rue d'Amsterdam, 75008, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Stimunity, 57 Rue d'Amsterdam, 75008, Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zahn, Roland" sort="Zahn, Roland" uniqKey="Zahn R" first="Roland" last="Zahn">Roland Zahn</name>
<affiliation wicri:level="3"><nlm:affiliation>Janssen Vaccines & Prevention B.V., 2333 CN, Leiden, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Janssen Vaccines & Prevention B.V., 2333 CN, Leiden</wicri:regionArea>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kikkert, Marjolein" sort="Kikkert, Marjolein" uniqKey="Kikkert M" first="Marjolein" last="Kikkert">Marjolein Kikkert</name>
<affiliation wicri:level="3"><nlm:affiliation>Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, 2333 ZA, Leiden, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, 2333 ZA, Leiden</wicri:regionArea>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Snijder, Eric" sort="Snijder, Eric" uniqKey="Snijder E" first="Eric" last="Snijder">Eric Snijder</name>
<affiliation wicri:level="3"><nlm:affiliation>Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, 2333 ZA, Leiden, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, 2333 ZA, Leiden</wicri:regionArea>
<placeName><settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Van Kuppeveld, Frank" sort="Van Kuppeveld, Frank" uniqKey="Van Kuppeveld F" first="Frank" last="Van Kuppeveld">Frank Van Kuppeveld</name>
<affiliation wicri:level="4"><nlm:affiliation>Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL, Utrecht, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL, Utrecht</wicri:regionArea>
<placeName><settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
<orgName type="university">Université d'Utrecht</orgName>
</affiliation>
</author>
<author><name sortKey="Fouchier, Ron" sort="Fouchier, Ron" uniqKey="Fouchier R" first="Ron" last="Fouchier">Ron Fouchier</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Viroscience, Erasmus MC, 3015 GD, Rotterdam, the Netherlands.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Department of Viroscience, Erasmus MC, 3015 GD, Rotterdam</wicri:regionArea>
<placeName><settlement type="city">Rotterdam</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hiscott, John" sort="Hiscott, John" uniqKey="Hiscott J" first="John" last="Hiscott">John Hiscott</name>
<affiliation wicri:level="3"><nlm:affiliation>Istituto Pasteur Italia Cenci Bolognetti Foundation, 00161, Rome, Italy. Electronic address: john.hiscott@istitutopasteur.it.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Istituto Pasteur Italia Cenci Bolognetti Foundation, 00161, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Virus research</title>
<idno type="eISSN">1872-7492</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (therapeutic use)</term>
<term>Betacoronavirus (drug effects)</term>
<term>Betacoronavirus (immunology)</term>
<term>Biomedical Research (methods)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (economics)</term>
<term>Delivery of Health Care (economics)</term>
<term>Delivery of Health Care (methods)</term>
<term>Education, Medical (methods)</term>
<term>Host-Pathogen Interactions (physiology)</term>
<term>Humans (MeSH)</term>
<term>Immunity, Innate (immunology)</term>
<term>Pandemics (economics)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pneumonia, Viral (economics)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antiviraux (usage thérapeutique)</term>
<term>Betacoronavirus (effets des médicaments et des substances chimiques)</term>
<term>Betacoronavirus (immunologie)</term>
<term>Enseignement médical (méthodes)</term>
<term>Humains (MeSH)</term>
<term>Immunité innée (immunologie)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Infections à coronavirus (économie)</term>
<term>Interactions hôte-pathogène (physiologie)</term>
<term>Pandémies (économie)</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Pneumopathie virale (économie)</term>
<term>Prestations des soins de santé (méthodes)</term>
<term>Prestations des soins de santé (économie)</term>
<term>Recherche biomédicale (méthodes)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Coronavirus Infections</term>
<term>Delivery of Health Care</term>
<term>Pandemics</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Betacoronavirus</term>
<term>Immunité innée</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Betacoronavirus</term>
<term>Immunity, Innate</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Biomedical Research</term>
<term>Delivery of Health Care</term>
<term>Education, Medical</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Enseignement médical</term>
<term>Prestations des soins de santé</term>
<term>Recherche biomédicale</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Interactions hôte-pathogène</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Host-Pathogen Interactions</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pandémies</term>
<term>Pneumopathie virale</term>
<term>Prestations des soins de santé</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Humains</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The past century has witnessed major advances in the control of many infectious diseases, yet outbreaks and epidemics caused by (re-) emerging RNA viruses continue to pose a global threat to human health. As illustrated by the global COVID19 pandemic, high healthcare costs, economic disruption and loss of productivity reinforce the unmet medical need to develop new antiviral strategies to combat not only the current pandemic but also future viral outbreaks. Pivotal for effective anti-viral defense is the innate immune system, a first line host response that senses and responds to virus infection. While molecular details of the innate immune response are well characterized, this research field is now being revolutionized with the recognition that cell metabolism has a major impact on the antiviral and inflammatory responses to virus infections. A detailed understanding of the role of metabolic regulation with respect to antiviral and inflammatory responses, together with knowledge of the strategies used by viruses to exploit immunometabolic pathways, will ultimately change our understanding and treatment of pathogenic viral diseases. INITIATE is a Marie Sklodowska-Curie Actions Innovative Training Network (MSCA-ITN), with the goal to train 15 early stage PhD researchers (ESRs) to become experts in antiviral immunometabolism (https://initiate-itn.eu/). To this end, INITIATE brings together a highly complementary international team of academic and corporate leaders from 7 European countries, with outstanding track records in the historically distinct research fields of virology, immunology and metabolism. The ESRs of INITIATE are trained in these interdisciplinary research fields through individual investigator-driven research projects, specialized scientific training events, workshops on academia-industry interactions, outreach & communication. INITIATE will deliver a new generation of creative and entrepreneurial researchers who will be able to face the inevitable future challenges in combating viral diseases.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32730781</PMID>
<DateCompleted><Year>2020</Year>
<Month>09</Month>
<Day>15</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>09</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7492</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>287</Volume>
<PubDate><Year>2020</Year>
<Month>10</Month>
<Day>02</Day>
</PubDate>
</JournalIssue>
<Title>Virus research</Title>
<ISOAbbreviation>Virus Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network.</ArticleTitle>
<Pagination><MedlinePgn>198094</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0168-1702(20)30940-0</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virusres.2020.198094</ELocationID>
<Abstract><AbstractText>The past century has witnessed major advances in the control of many infectious diseases, yet outbreaks and epidemics caused by (re-) emerging RNA viruses continue to pose a global threat to human health. As illustrated by the global COVID19 pandemic, high healthcare costs, economic disruption and loss of productivity reinforce the unmet medical need to develop new antiviral strategies to combat not only the current pandemic but also future viral outbreaks. Pivotal for effective anti-viral defense is the innate immune system, a first line host response that senses and responds to virus infection. While molecular details of the innate immune response are well characterized, this research field is now being revolutionized with the recognition that cell metabolism has a major impact on the antiviral and inflammatory responses to virus infections. A detailed understanding of the role of metabolic regulation with respect to antiviral and inflammatory responses, together with knowledge of the strategies used by viruses to exploit immunometabolic pathways, will ultimately change our understanding and treatment of pathogenic viral diseases. INITIATE is a Marie Sklodowska-Curie Actions Innovative Training Network (MSCA-ITN), with the goal to train 15 early stage PhD researchers (ESRs) to become experts in antiviral immunometabolism (https://initiate-itn.eu/). To this end, INITIATE brings together a highly complementary international team of academic and corporate leaders from 7 European countries, with outstanding track records in the historically distinct research fields of virology, immunology and metabolism. The ESRs of INITIATE are trained in these interdisciplinary research fields through individual investigator-driven research projects, specialized scientific training events, workshops on academia-industry interactions, outreach & communication. INITIATE will deliver a new generation of creative and entrepreneurial researchers who will be able to face the inevitable future challenges in combating viral diseases.</AbstractText>
<CopyrightInformation>Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van den Hoogen</LastName>
<ForeName>Bernadette</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Department of Viroscience, Erasmus MC, 3015 GD, Rotterdam, the Netherlands. Electronic address: b.vandenhoogen@erasmusmc.nl.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Santoni</LastName>
<ForeName>Angela</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Istituto Pasteur Italia Cenci Bolognetti Foundation, 00161, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sciumé</LastName>
<ForeName>Giuseppe</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Istituto Pasteur Italia Cenci Bolognetti Foundation, 00161, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bowie</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152 - 160 Pearse St., Dublin 2, Ireland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>O'Farrelly</LastName>
<ForeName>Cliona</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152 - 160 Pearse St., Dublin 2, Ireland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>O'Neill</LastName>
<ForeName>Luke</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152 - 160 Pearse St., Dublin 2, Ireland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Anthonsen</LastName>
<ForeName>Marit</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Laboratory Medicine, Children's and Women's Health, Faculty of Medicine, Norwegian University of Science and Technology, 7006, Trondheim, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pardali</LastName>
<ForeName>Katerina</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>AstraZeneca, Pepparedsleden 1, 431 50, Mölndal, Gothenburg, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Young</LastName>
<ForeName>Simon</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>AstraZeneca, Pepparedsleden 1, 431 50, Mölndal, Gothenburg, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bergthaler</LastName>
<ForeName>Andreas</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090, Vienna, Austria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Manel</LastName>
<ForeName>Nicolas</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Stimunity, 57 Rue d'Amsterdam, 75008, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zahn</LastName>
<ForeName>Roland</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Janssen Vaccines & Prevention B.V., 2333 CN, Leiden, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kikkert</LastName>
<ForeName>Marjolein</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, 2333 ZA, Leiden, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Snijder</LastName>
<ForeName>Eric</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, 2333 ZA, Leiden, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>van Kuppeveld</LastName>
<ForeName>Frank</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3584 CL, Utrecht, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Fouchier</LastName>
<ForeName>Ron</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Department of Viroscience, Erasmus MC, 3015 GD, Rotterdam, the Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hiscott</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Istituto Pasteur Italia Cenci Bolognetti Foundation, 00161, Rome, Italy. Electronic address: john.hiscott@istitutopasteur.it.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>07</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Virus Res</MedlineTA>
<NlmUniqueID>8410979</NlmUniqueID>
<ISSNLinking>0168-1702</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004501" MajorTopicYN="N">Education, Medical</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Coronavirus</Keyword>
<Keyword MajorTopicYN="Y">Immunometabolism</Keyword>
<Keyword MajorTopicYN="Y">Influenza virus</Keyword>
<Keyword MajorTopicYN="Y">Innate immunity</Keyword>
<Keyword MajorTopicYN="Y">Innovative training network</Keyword>
<Keyword MajorTopicYN="Y">Pneumovirus</Keyword>
<Keyword MajorTopicYN="Y">Virology</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>07</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>07</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>07</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>7</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>9</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>7</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32730781</ArticleId>
<ArticleId IdType="pii">S0168-1702(20)30940-0</ArticleId>
<ArticleId IdType="doi">10.1016/j.virusres.2020.198094</ArticleId>
<ArticleId IdType="pmc">PMC7384980</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Autriche</li>
<li>France</li>
<li>Irlande (pays)</li>
<li>Italie</li>
<li>Norvège</li>
<li>Pays-Bas</li>
<li>Suède</li>
</country>
<region><li>Hollande-Méridionale</li>
<li>Latium</li>
<li>Trøndelag</li>
<li>Utrecht (province)</li>
<li>Vienne (Autriche)</li>
<li>Île-de-France</li>
</region>
<settlement><li>Leyde</li>
<li>Paris</li>
<li>Rome</li>
<li>Rotterdam</li>
<li>Trondheim</li>
<li>Utrecht</li>
<li>Vienne (Autriche)</li>
</settlement>
<orgName><li>Université d'Utrecht</li>
</orgName>
</list>
<tree><country name="Pays-Bas"><region name="Hollande-Méridionale"><name sortKey="Van Den Hoogen, Bernadette" sort="Van Den Hoogen, Bernadette" uniqKey="Van Den Hoogen B" first="Bernadette" last="Van Den Hoogen">Bernadette Van Den Hoogen</name>
</region>
<name sortKey="Fouchier, Ron" sort="Fouchier, Ron" uniqKey="Fouchier R" first="Ron" last="Fouchier">Ron Fouchier</name>
<name sortKey="Kikkert, Marjolein" sort="Kikkert, Marjolein" uniqKey="Kikkert M" first="Marjolein" last="Kikkert">Marjolein Kikkert</name>
<name sortKey="Snijder, Eric" sort="Snijder, Eric" uniqKey="Snijder E" first="Eric" last="Snijder">Eric Snijder</name>
<name sortKey="Van Kuppeveld, Frank" sort="Van Kuppeveld, Frank" uniqKey="Van Kuppeveld F" first="Frank" last="Van Kuppeveld">Frank Van Kuppeveld</name>
<name sortKey="Zahn, Roland" sort="Zahn, Roland" uniqKey="Zahn R" first="Roland" last="Zahn">Roland Zahn</name>
</country>
<country name="Italie"><region name="Latium"><name sortKey="Santoni, Angela" sort="Santoni, Angela" uniqKey="Santoni A" first="Angela" last="Santoni">Angela Santoni</name>
</region>
<name sortKey="Hiscott, John" sort="Hiscott, John" uniqKey="Hiscott J" first="John" last="Hiscott">John Hiscott</name>
<name sortKey="Sciume, Giuseppe" sort="Sciume, Giuseppe" uniqKey="Sciume G" first="Giuseppe" last="Sciumé">Giuseppe Sciumé</name>
</country>
<country name="Irlande (pays)"><noRegion><name sortKey="Bowie, Andrew" sort="Bowie, Andrew" uniqKey="Bowie A" first="Andrew" last="Bowie">Andrew Bowie</name>
</noRegion>
<name sortKey="O Farrelly, Cliona" sort="O Farrelly, Cliona" uniqKey="O Farrelly C" first="Cliona" last="O'Farrelly">Cliona O'Farrelly</name>
<name sortKey="O Neill, Luke" sort="O Neill, Luke" uniqKey="O Neill L" first="Luke" last="O'Neill">Luke O'Neill</name>
</country>
<country name="Norvège"><region name="Trøndelag"><name sortKey="Anthonsen, Marit" sort="Anthonsen, Marit" uniqKey="Anthonsen M" first="Marit" last="Anthonsen">Marit Anthonsen</name>
</region>
</country>
<country name="Suède"><noRegion><name sortKey="Pardali, Katerina" sort="Pardali, Katerina" uniqKey="Pardali K" first="Katerina" last="Pardali">Katerina Pardali</name>
</noRegion>
<name sortKey="Young, Simon" sort="Young, Simon" uniqKey="Young S" first="Simon" last="Young">Simon Young</name>
</country>
<country name="Autriche"><region name="Vienne (Autriche)"><name sortKey="Bergthaler, Andreas" sort="Bergthaler, Andreas" uniqKey="Bergthaler A" first="Andreas" last="Bergthaler">Andreas Bergthaler</name>
</region>
</country>
<country name="France"><region name="Île-de-France"><name sortKey="Manel, Nicolas" sort="Manel, Nicolas" uniqKey="Manel N" first="Nicolas" last="Manel">Nicolas Manel</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D64 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D64 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32730781
   |texte=   Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32730781" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021

	Serveur d'exploration sur la COVID en France
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la COVID en France

Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network.

Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki